SCHEMBL1355820

SCHEMBL1355820

CCOC(=O)c1cnn(-c2cccc3ccccc23)c1N

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.66
HPGD P15428 3/20 0.66
NPC1 O15118 6/20 0.63
MAPT P10636 6/20 0.63
TSHR P16473 4/20 0.63
RAB9A P51151 6/20 0.61
TP53 P04637 1/20 0.61
HTT P42858 1/20 0.60
SMN1; SMN2 Q16637 4/20 0.58
KMT2A Q03164 3/20 0.58
MEN1 O00255 1/20 0.58
HSD17B10 Q99714 2/20 0.54
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52
RECQL P46063 1/20 0.52
CDC25B P30305 1/20 0.51
ALOX15 P16050 1/20 0.50
LMNA P02545 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31117114 1.00 ALDH1A1 (0.66) ALDH1A1HPGDNPC1MAPTTSHR
SCHEMBL31117175 0.91 ALDH1A1 (0.61) ALDH1A1HPGDNPC1MAPTTSHR
SCHEMBL6312871 0.88 ALDH1A1 (0.56) ALDH1A1HPGDNPC1MAPTTSHR
SCHEMBL859755 0.87 CDC25B (0.52) ALDH1A1HPGDNPC1MAPTTSHR
SCHEMBL17844204 0.85 ALDH1A1 (0.72) ALDH1A1HPGDNPC1MAPTTSHR
SCHEMBL18172002 0.85 ALDH1A1 (0.72) ALDH1A1HPGDNPC1MAPTTSHR
SCHEMBL13131101 0.83 ALDH1A1 (0.69) ALDH1A1HPGDNPC1MAPTTSHR
SCHEMBL31117051 0.83 ALDH1A1 (0.69) ALDH1A1HPGDNPC1MAPTTSHR
SCHEMBL3520425 0.83 ALDH1A1 (0.69) ALDH1A1HPGDNPC1MAPTTSHR
SCHEMBL31116973 0.83 ALDH1A1 (0.69) ALDH1A1HPGDNPC1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110281821-A9 Modulators of Mitotic Kinases BIOGEN IDEC MA INC. (US) 2011-11-17 US disclosed
US-20100249067-A1 Modulators of Mitotic Kinases BIOGEN IDEC MA INC. (US) 2010-09-30 US disclosed
US-20100190787-A1 Modulators of Mitotic Kinases BIOGEN IDEC MA INC 2010-07-29 US disclosed
EP-2108020-A2 1-H-PYRAZOLO[3,4B]PYRIMIDINE DERIVATIVES AND THEIR USE AS MODULATORS OF MITOTIC KINASES Biogen Idec MA, Inc. (US) 2009-10-14 EP disclosed
EP-2108019-A2 1-H-PYRAZOLO[3,4B]PYRIMIDINE DERIVATIVES AND THEIR USE AS MODULATORS OF MITOTIC KINASES Biogen Idec MA, Inc. (US) 2009-10-14 EP disclosed
WO-2008094575-A2 1-H-PYRAZOLO(3,4B)PYRIMIDINE DERIVATIVES AND THEIR USE AS MODULATORS OF MITOTIC KINASES BIOGEN IDEC MA INC. (US) 2008-08-07 WO disclosed
WO-2008094602-A2 1-H-PYRAZOLO (3,4B) PYRIMIDINE DERIVATIVES AND THEIR USE AS MODULATORS OF MITOTIC KINASES BIOGEN IDEC MA INC. (US) 2008-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249067-A1 Modulators of Mitotic Kinases BUB1, BUB1B, CDK1 ALDH1A1 4063/4885HPGD 2322/4885NPC1 2447/4885
US-20100190787-A1 Modulators of Mitotic Kinases CDK1, BUB1, BUB1B ALDH1A1 4286/4885HPGD 2070/4885NPC1 2632/4885
US-20110281821-A9 Modulators of Mitotic Kinases BUB1, BUB1B, CDK1 ALDH1A1 4063/4885HPGD 2322/4885NPC1 2447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.